Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01402466 · ClinicalTrials.gov registry record · Phase 2

Urban Health Study II

A Phase 2 study, sponsored by RTI International.

Completed
Registry status
Phase 2
Development phase
49
Enrollment target

NCT01402466: Completed Phase 2 study, sponsored by RTI International.

NCT01402466 is a Phase 2 study that has completed, run by RTI International. The registered enrollment target is 49 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (63% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01402466, a Phase 2 study, has completed, sponsored by RTI International.

COMPLETED
Registry status
Phase 2
Development phase
49 participants
Enrollment target

Study Summary

The study will test an intervention to help HIV-positive people achieve consistency of HIV care while transitioning in and out of jail.

Primary Outcome

Changes in viral load over time will be compared between the standard referral and Project Bridge Groups

Interventions

  • BEHAVIORAL Standard Referral
  • BEHAVIORAL Project Bridge

Trial Details

FieldValue
Enrollment Target 49 participants
Start Date 2011-08
Est. Completion 2014-12
Phase Phase 2
RTI International

45 total trials

What the finished NCT01402466 record still lists

NCT01402466 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 49 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (63% lower).

The record links to 0 conditions, and to 2 interventions - of which Standard Referral is the first listed.

NCT01402466 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01402466 about?

NCT01402466 is a clinical study titled "Urban Health Study II". The study will test an intervention to help HIV-positive people achieve consistency of HIV care while transitioning in and out of jail.

What is the current status of trial NCT01402466?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 49 participants. The study started on 2011-08. Estimated completion is 2014-12.

What interventions are being tested in trial NCT01402466?

The interventions under investigation include: Standard Referral (BEHAVIORAL), Project Bridge (BEHAVIORAL).

Who is sponsoring clinical trial NCT01402466?

This trial is sponsored by RTI International, which has 45 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01402466's enrollment target sits among peer trials

49 1261st of 2000 higher than 736 of 2,000 other Phase 2 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02704858 · 49 participants · Phase 1

    Safety and Efficacy Study in Recurrent or Progressive Grade III or IV IDH1 Mutated Glioma

  • NCT03516708 · 49 participants · Phase 1

    Epacadostat (INCB024360) Added to Preoperative Chemoradiation in Patients With Locally Advanced Rectal Cancer

  • NCT03692429 · 49 participants · Phase 1

    alloSHRINK - Standard cHemotherapy Regimen and Immunotherapy With Allogeneic NKG2D-based CYAD-101 Chimeric Antigen Receptor T-cells

  • NCT04329494 · 49 participants · Phase 1

    PIPAC for the Treatment of Peritoneal Carcinomatosis in Patients With Ovarian, Uterine, Appendiceal, Colorectal, or Gastric Cancer

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01402466, the US trial registry maintained by the National Library of Medicine. NCT01402466 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.